U.S. to buy Siga's IV drug worth $26 mln to fight monkeypox outbreak

SIGA Technologies

09/08/2022 12:40

Aug 9 (Reuters) - Siga Technologies Inc  SIGA.O  said on
Tuesday the U.S. government has decided to procure its
intravenous (IV) formulation of antiviral drug Tpoxx worth $26
million at a time when the country is fighting an outbreak of
monkeypox cases.
 

 (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))